Table 2 KRAS mutation frequencies observed in borderline malignancies
From: KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
| borderline | |||
|---|---|---|---|
| histotype | n | mutated | % mutated |
| serous | 20 | 7 | 35.00 |
| endometroid | 1 | 0 | 0.00 |
| mucinous | 6 | 3 | 50.00 |
| unknown | 2 | 0 | 0.00 |
| total | 29 | 10 | 34.48 |